Evidence map›Paper›PMID 42353665›Full record

ArticleAntibiotics (Basel, Switzerland)2026

Antimicrobial Resistance, Biofilm Formation, and Phylogenetic Distribution of

Luis Asdrúval Zepeda-Gutiérrez, Sol Ramírez-Ochoa, Mauricio Alfredo Ambriz-Alarcón, Enrique Cervantes-Pérez, Araceli Castillo-Romero, Karel Cesar Licona-Lasteros, Rafael Cortés-Zárate

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Luis Asdrúval Zepeda-GutiérrezPrograma de Maestría en Microbiología Médica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.ORCID 0000-0003-1177-1815
Sol Ramírez-OchoaDepartamento de Medicina Interna, Hospital Civil de Guadalajara Fray Antonio Alcalde, Universidad de Guadalajara, Guadalajara 44280, Jalisco, Mexico.
Mauricio Alfredo Ambriz-AlarcónDepartamento de Medicina Interna, Hospital Civil de Guadalajara Fray Antonio Alcalde, Universidad de Guadalajara, Guadalajara 44280, Jalisco, Mexico.ORCID 0000-0002-0798-7384
Enrique Cervantes-PérezDepartamento de Medicina Interna, Hospital Civil de Guadalajara Fray Antonio Alcalde, Universidad de Guadalajara, Guadalajara 44280, Jalisco, Mexico.ORCID 0000-0002-6333-9082
Araceli Castillo-RomeroCentro de Investigación de Enfermedades Infectocontagiosas, Departamento de Microbiología y Patología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada 950, Col. Independencia, Guadalajara 44340, Jalisco, Mexico.ORCID 0000-0002-4461-7673
Karel Cesar Licona-LasterosLaboratorio de Sistemas Biológicos, Departamento de Ciencias de la Salud, Centro Universitario de los Valles, Universidad de Guadalajara, Carretera Guadalajara-Ameca Km. 45.5, Ameca 46600, Jalisco, Mexico.
Rafael Cortés-ZárateCentro de Investigación de Enfermedades Infectocontagiosas, Departamento de Microbiología y Patología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada 950, Col. Independencia, Guadalajara 44340, Jalisco, Mexico.ORCID 0000-0002-2290-1999

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectives

methodsSeventy isolates (September 2023-September 2024) underwent susceptibility testing (CLSI M100, 35th edition), multiplex PCR for

resultsESBL phenotype and MDR were detected in 57.1% and 58.6% of isolates. After BH-FDR correction, ESBL production was significantly associated with amikacin (OR = 5.55; 95% CI: 1.80-18.74; q = 0.002) and TMP-SMX non-susceptibility (OR = 3.00; 95% CI: 1.02-9.23; q = 0.036); ciprofloxacin non-susceptibility was linked to MDR status (OR = 7.21; 95% CI: 1.28-75.66; q = 0.017) but not ESBL phenotype. Biofilm was detected in 77.1% of isolates.

conclusionsThe high prevalence of ESBL-producing and MDR

Indexed as

antimicrobial resistancebiofilm formationESBLEscherichia colimultidrug resistancephylogenetic groupsurinary tract infection

Identifiers

PMID42353665
PMCPMC13296134

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.